Aggressive multiple sclerosis (2): Treatment

Multiple Sclerosis : Clinical and Laboratory Research
Georgina Arrambide2018 ECTRIMS Focused Workshop Group

Abstract

The natural history of multiple sclerosis (MS) is highly heterogeneous. A subgroup of patients has what might be termed aggressive MS. These patients may have frequent, severe relapses with incomplete recovery and are at risk of developing greater and permanent disability at the earlier stages of the disease. Their therapeutic window of opportunity may be narrow, and while it is generally considered that they will benefit from starting early with a highly efficacious treatment, a unified definition of aggressive MS does not exist and data on its treatment are largely lacking. Based on discussions at an international focused workshop sponsored by the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), we review our current knowledge about treatment of individuals with aggressive MS. We analyse the available evidence, identify gaps in knowledge and suggest future research needed to fill those gaps. A companion paper details the difficulties in developing a consensus about what defines aggressive MS.

References

Dec 31, 2002·Lancet·Hans-Peter HartungUNKNOWN Mitoxantrone in Multiple Sclerosis Study Group (MIMS)
Sep 23, 2008·Multiple Sclerosis : Clinical and Laboratory Research·J FagiusG Oberg
Mar 25, 2009·Journal of Neurology·Michael HutchinsonUNKNOWN AFFIRM and SENTINEL Investigators
May 15, 2009·Neurology·N MakhaniT Chitnis
Mar 16, 2011·Archives of Neurology·Setty M MagañaClaudia F Lucchinetti
Mar 26, 2011·Journal of Neurology, Neurosurgery, and Psychiatry·G EdanUNKNOWN French–Italian Mitoxantrone Interferon-beta-1b Trial Group
Jun 15, 2011·Multiple Sclerosis : Clinical and Laboratory Research·C PapeixC Lubetzki
Jan 8, 2013·Journal of Neurology·Ludwig KapposChristophe Hotermans
Apr 2, 2013·Clinical Therapeutics·Jose E Meca-LallanaJose J Martín-Fernández
Dec 7, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lorry G Rubin Infectious Diseases Society of America
Apr 29, 2014·Pediatric Neurology·Shannon J BeresEmmanuelle Waubant
May 14, 2014·JAMA Neurology·Aiden HaghikiaKerstin Hellwig
Oct 12, 2014·Multiple Sclerosis : Clinical and Laboratory Research·Sandra VukusicChristian Confavreux
Feb 13, 2015·Neurology·Giovanni L MancardiUNKNOWN ASTIMS Haemato-Neurological Collaborative Group On behalf of the Autoimmune Disease Working Party ADWP of the European Group
Mar 21, 2015·European Neurology·Álvaro Cobo-CalvoSergio Martínez Yélamos
Mar 22, 2015·Current Treatment Options in Neurology·Carolyn Bevan, Jeffrey M Gelfand
Jun 3, 2015·Nature Reviews. Neurology·Carolina A RushMark S Freedman
Jun 30, 2015·Current Medical Research and Opinion·T DerfussD L Tomic
Mar 5, 2016·Nature Reviews. Neurology·Alexander WinkelmannUwe K Zettl
May 3, 2016·Therapeutic Advances in Neurological Disorders·Patricia K Coyle
May 22, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Maria Pia SormaniGianluigi Mancardi
Aug 31, 2016·Journal of Child Neurology·Seema Bangalore HanumantheEmmanuelle Waubant
Aug 31, 2016·Neurology·Tanuja ChitnisDaniela Pohl
Dec 22, 2016·The New England Journal of Medicine·Xavier MontalbanUNKNOWN ORATORIO Clinical Investigators
Dec 23, 2016·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Paul D MorrisCharbel Sandroussi
Feb 28, 2017·JAMA Neurology·Paolo A MuraroUNKNOWN Multiple Sclerosis–Autologous Hematopoietic Stem Cell Transplantation (MS-AHSCT) Long-term Outcomes Study Group

❮ Previous
Next ❯

Citations

Nov 28, 2020·Annals of Neurology·Mylyne ThamBogdan F Popescu
May 15, 2021·La Presse médicale·Jean-Christophe BrissetUNKNOWN Imaging Group of the 'Observatoire francais de la sclérose en plaques'
Jun 25, 2021·Expert Review of Pharmacoeconomics & Outcomes Research·Olivier VandhuickArnaud Kwiatkowski

❮ Previous
Next ❯

Software Mentioned

TREAT
DELIVER
MS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved